Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).

Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).

Item
http://www.wikidata.org/entity/Q37950459
The circadian clock in cancer development and therapyPotential utility of cancer-specific biomarkers for assessing response to hormonal treatments in metastatic prostate cancer.Aldo-keto reductase family 1 member C3 (AKR1C3) is a biomarker and therapeutic target for castration-resistant prostate cancer.Mechanism and Function of Angiogenin in Prostate Cancer.The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer.Current, new and novel therapy for castration-resistant prostate cancer.Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer.A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signalingThe combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo.From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer.Pain questionnaire performance in advanced prostate cancer: comparative results from two international clinical trials.ATM‑JAK‑PD‑L1 signaling pathway inhibition decreases EMT and metastasis of androgen‑independent prostate cancer.
P2860

Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).

Item
http://www.wikidata.org/entity/Q37950459
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
@en
Novel therapeutics for the management of castration-resistant prostate cancer
@nl
type
label
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
@en
Novel therapeutics for the management of castration-resistant prostate cancer
@nl
prefLabel
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
@en
Novel therapeutics for the management of castration-resistant prostate cancer
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
@en
P2093
P2860
P304
P31
P356
10.1111/J.1464-410X.2011.10643.X
P433
P478
P50
P577
P698